Inspira Stock to Gain From its Appearance at Annual ELSO Conference
At the 34th annual ELSO conference in Detroit, IINN will present its FDA-cleared latest and future technology, the INSPIRA ART100 system.
IINN Stock Gains on Second US Patent Approval for VORTX System
Inspira secures a second U.S. Patent approval for the VORTX orbiting blood oxygenation delivery system.
Favorable Clinical Results for HYLA Sensor Might Boost Inspira Stock
IINN plans to report clinical results for its new HYLA blood sensor in open-heart surgery patients in the fourth quarter of 2024.
INSPIRA (IINN) CART Gets FDA Listing, to Enhance Healthcare
Inspira (IINN) announces FDA listing of its INSPIRA CART, designed for use with the ART100 system, enhancing healthcare delivery during cardiopulmonary bypass.
Inspira (IINN) Unveils Business Targets for 2024-25
Inspira (IINN) discloses business goals for 2024-25 with the rapid promotion of INSPIRA ART100 and the development of INSPIRA ART (Gen 2).
Inspira Technologies' (IINN) ART100 Gets FDA 510(k) Grant
Inspira Technologies' (IINN) ART100 recent approval highlights the company's innovative advancements in medical technology.
